Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Langenfeld

Showing results (1-10 of 15) with videos related to

Pageof 2
Sort By:
Journal of Human Hypertension|November 1, 1995
Salt and left ventricular hypertrophy: what are the links?M R Langenfeld, R E Schmieder
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1997
Endogenous erythropoietin correlates with blood pressure in essential hypertensionR E Schmieder, M R Langenfeld, K F Hilgers
European Heart Journal|July 4, 1998
Impact of dietary sodium intake on left ventricular diastolic filling in early essential hypertensionM R Langenfeld, H Schobel, R Veelken, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1997
Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension?M R Langenfeld, R Veelken, H P Schobel, et al.
Circulation|September 29, 1999
1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin IIK F Hilgers, M R Langenfeld, M Schlaich, et al.
Clinical Science (London, England : 1979)|November 29, 2001
Endothelin-1 plus oxidized low-density lipoprotein, but neither alone, increase human monocyte adhesion to endothelial cellsM R Langenfeld, S Nakhla, A K Death, et al.
American Journal of Hypertension|November 5, 1997
Impact of alpha- versus beta-blockers on hypertensive target organ damage: results of a double-blind, randomized, controlled clinical trialR E Schmieder, M R Langenfeld, C D Gatzka, et al.
Journal of Human Hypertension|December 1, 1996
Antihypertensive efficacy and orthostatic tolerance of bunazosin vs nitrendipine: a multicentre double-blind randomized controlled studyM R Langenfeld, M Bräutigam, G Weidinger, et al.
Clinical Nephrology|April 17, 1998
Inadequate suppression of angiotensin II modulates left ventricular structure in humansM P Schlaich, H P Schobel, M R Langenfeld, et al.
Journal of Hypertension|August 25, 1999
Hyper-responsiveness to angiotensin II is related to cardiac structural adaptation in hypertensive subjectsA U Klingbeil, H Schobel, M R Langenfeld, et al.
Pageof 2

Showing results (1-10 of 15) with videos related to

Sort By:
Pageof 2
Journal of Human Hypertension|November 1, 1995
Salt and left ventricular hypertrophy: what are the links?M R Langenfeld, R E Schmieder
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|March 1, 1997
Endogenous erythropoietin correlates with blood pressure in essential hypertensionR E Schmieder, M R Langenfeld, K F Hilgers
European Heart Journal|July 4, 1998
Impact of dietary sodium intake on left ventricular diastolic filling in early essential hypertensionM R Langenfeld, H Schobel, R Veelken, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|June 1, 1997
Is endogenous erythropoietin a pathogenetic factor in the development of essential hypertension?M R Langenfeld, R Veelken, H P Schobel, et al.
Circulation|September 29, 1999
1166 A/C polymorphism of the angiotensin II type 1 receptor gene and the response to short-term infusion of angiotensin IIK F Hilgers, M R Langenfeld, M Schlaich, et al.
Clinical Science (London, England : 1979)|November 29, 2001
Endothelin-1 plus oxidized low-density lipoprotein, but neither alone, increase human monocyte adhesion to endothelial cellsM R Langenfeld, S Nakhla, A K Death, et al.
American Journal of Hypertension|November 5, 1997
Impact of alpha- versus beta-blockers on hypertensive target organ damage: results of a double-blind, randomized, controlled clinical trialR E Schmieder, M R Langenfeld, C D Gatzka, et al.
Journal of Human Hypertension|December 1, 1996
Antihypertensive efficacy and orthostatic tolerance of bunazosin vs nitrendipine: a multicentre double-blind randomized controlled studyM R Langenfeld, M Bräutigam, G Weidinger, et al.
Clinical Nephrology|April 17, 1998
Inadequate suppression of angiotensin II modulates left ventricular structure in humansM P Schlaich, H P Schobel, M R Langenfeld, et al.
Journal of Hypertension|August 25, 1999
Hyper-responsiveness to angiotensin II is related to cardiac structural adaptation in hypertensive subjectsA U Klingbeil, H Schobel, M R Langenfeld, et al.
Pageof 2